Share on StockTwits

Research analysts at Cowen and Company started coverage on shares of Trupanion (NASDAQ:TRUP) in a report released on Tuesday. The firm set an “outperform” rating and a $12.00 price target on the stock. Cowen and Company’s price target indicates a potential upside of 17.53% from the company’s current price.

Shares of Trupanion (NASDAQ:TRUP) traded up 0.64% on Tuesday, hitting $10.205. 61,361 shares of the company’s stock traded hands. Trupanion has a 1-year low of $9.31 and a 1-year high of $11.95. The stock’s 50-day moving average is $10.40 and its 200-day moving average is $10.40. The company’s market cap is $271.0 million.

Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity initiated coverage on shares of Trupanion in a research note on Tuesday. They set a “buy” rating and a $13.00 price target on the stock. Separately, analysts at Barclays initiated coverage on shares of Trupanion in a research note on Tuesday. They set an “overweight” rating and a $15.00 price target on the stock. Finally, analysts at Stifel Nicolaus initiated coverage on shares of Trupanion in a research note on Tuesday. They set a “buy” rating and a $18.00 price target on the stock. Five analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus target price of $14.40.

Trupanion, Inc, is a direct-to-consumer monthly subscription service providing a medical insurance plan for cats and dogs throughout the United States, Canada and Puerto Rico.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.